All Comments by Brigita Urbanc
Go to another page:
- 1
- 2
- Soluble Oligomer Assay Rivals Other Biomarkers in Detecting Preclinical AD
- Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide.
- Amyloid Deposits Not Always Toxic to Cells
- Electron Microscope Yields Finer Structure of α-Synuclein, Aβ Fibrils
- Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
- Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to β-sheet in amyloid fibril formation.
- The Toxic Fold? Aβ Dodecamers, Tetramers Show Their Conformations
- Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure.
- A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
- Low-power laser irradiation inhibiting Abeta25-35-induced PC12 cell apoptosis via PKC activation.
- Affibodies—Putting the β in Aβ?
- Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity.
- Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils.
- Linking folding with aggregation in Alzheimer's beta-amyloid peptides.
- Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus.